References
- LesneSKohMTKotilinekL A specific amyloid-beta protein assembly in the brain impairs memory Nature 2006 440 352 357 16541076
- MuckeL Neuroscience: Alzheimer’s disease Nature 2009 461 895 897 19829367
- TaylorJPHardyJFischbeckKH Toxic proteins in neurodegenerative disease Science 2002 296 1991 1995 12065827
- HardyJSelkoeDJ The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics Science 2002 297 353 356 12130773
- HoltzmanDM Alzheimer’s disease: moving towards a vaccine Nature 2008 454 418 420 18650906
- WalshDMKlyubinIFadeevaJV Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 2002 416 535 539 11932745
- Meyer-LuehmannMSpires-JonesTLPradaC Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease Nature 2008 451 720 724 18256671
- BohrmannBTjernbergLKunerP Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues J Biol Chem 1999 274 15990 15995 10347147
- CostaRFerreira-da-SilvaFSaraivaMJCardosoI Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor PLoS One 2008 3 e2899 18682830
- SchwarzmanALGregoriLVitekMP Transthyretin sequesters amyloid beta protein and prevents amyloid formation Proc Natl Acad Sci U S A 1994 91 8368 8372 8078889
- SteinTDJohnsonJA Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J Neurosci 2002 22 7380 7388 12196559
- HanssonSFAndreassonUWallM Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer’s disease patients J Alzheimers Dis 2009 16 389 397 19221428
- HuMChenJLiZY Gold nanostructures: engineering their plasmonic properties for biomedical applications Chem Soc Rev 2006 35 1084 1094 17057837
- MirkinCALetsingerRLMucicRCStorhoffJJ A DNA-based method for rationally assembling nanoparticles into macroscopic materials Nature 1996 382 607 609 8757129
- LinseSCabaleiro-LagoCXueWF Nucleation of protein fibrillation by nanoparticles Proc Natl Acad Sci U S A 2007 104 8691 8696 17485668
- EghtedariMLiopoAVCoplandJAOraevskyAAMotamediM Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells Nano Lett 2009 9 287 291 19072129
- KoganMJBastusNGAmigoR Nanoparticle-mediated local and remote manipulation of protein aggregation Nano Lett 2006 6 110 115 16402797
- BoisselierEAstrucD Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity Chem Soc Rev 2009 38 1759 1782 19587967
- GroenningMOlsenLvan de WeertMFlinkJMFrokjaerSJorgensenFS Study on the binding of Thioflavin T to beta-sheet-rich and non-beta-sheet cavities J Struct Biol 2007 158 358 369 17289401
- SousaMMCardosoIFernandesRGuimaraesASaraivaMJ Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates Am J Pathol 2001 159 1993 2000 11733349
- LovellMARobertsonJDTeesdaleWJCampbellJLMarkesberyWR Copper, iron and zinc in Alzheimer’s disease senile plaques J Neurol Sci 1998 158 47 52 9667777
- CurtainCCAliFVolitakisI Alzheimer’s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits J Biol Chem 2001 276 20466 20473 11274207
- AtwoodCSMoirRDHuangX Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis J Biol Chem 1998 273 12817 12826 9582309
- MartinsICKupersteinIWilkinsonH Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice EMBO J 2008 27 224 233 18059472